{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:15:04Z","timestamp":1790936104237,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1054\/blre.2001.0170","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T11:33:30Z","timestamp":1027683210000},"page":"3-5","source":"Crossref","is-referenced-by-count":29,"title":["Humanized mouse models of FcR clearance in immune platelet disorders"],"prefix":"10.1054","volume":"16","author":[{"given":"S.E.","family":"McKenzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1054\/blre.2001.0170_RF1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2007-1000375","article-title":"Anti-platelet antibody interactions with Fc receptor","volume":"21","author":"Rubinstein","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"10.1054\/blre.2001.0170_RF2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1055\/s-2007-1000378","article-title":"Functional effects of human antiplatelet antibodies","volume":"21","author":"Deckmyn","year":"1995","journal-title":"Semin Thromb Hemost"},{"key":"10.1054\/blre.2001.0170_RF3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2141.1991.tb08010.x","article-title":"Anti-GPIIb\/IIIa (CD41) monoclonal antibody-induced platelet activation requires Fc receptor-dependent cell\u2013cell interaction","volume":"79","author":"Anderson","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0170_RF4","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/blood.V80.9.2261.2261","article-title":"Response of human platelets to activating monoclonal antibodies: importance of FcRII (CD32) phenotype and level of expression","volume":"80","author":"Tomiyama","year":"1992","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0170_RF5","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1182\/blood.V81.7.1792.1792","article-title":"Human platelet aggregation by murine monoclonal antiplatelet antibodies is subtype-dependent","volume":"81","author":"De Reys","year":"1993","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0170_RF6","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1055\/s-0038-1649982","article-title":"Role of FcRIIa gene polymorphism in human platelet activation by monoclonal antibodies","volume":"74","author":"Bachelot","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1054\/blre.2001.0170_RF7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/CDLI.1.6.640-644.1994","article-title":"Genetic diversity in human Fc receptor II for Immunoglobulin G: Fc receptor IIA ligand-binding polymorphism","volume":"1","author":"Reilly","year":"1994","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1054\/blre.2001.0170_RF8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJM198010023031404","article-title":"Heparin-associated thrombocytopenia","volume":"303","author":"Cines","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2001.0170_RF9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1365-2141.1997.d01-2056.x","article-title":"Heparin-induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular diseases","volume":"96","author":"Kappers-Klunne","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0170_RF10","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood.V84.11.3691.bloodjournal84113691","article-title":"Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia","volume":"84","author":"Warkentin","year":"1994","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0170_RF11","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1182\/blood.V81.4.988.988","article-title":"Increased expression of platelet IgG Fc receptors in immune heparin-induced thrombocytopenia","volume":"81","author":"Chong","year":"1993","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0170_RF12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1096-8652(199703)54:3<196::AID-AJH4>3.0.CO;2-R","article-title":"Characterization of the humoral immune response in heparin-induced thrombocytopenia","volume":"54","author":"Suh","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0170_RF13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.V89.2.370","article-title":"Fc gamma RIIA H\/R 131 polymorphism, subclass-specific IgG anti-heparin\/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis","volume":"89","author":"Arepally","year":"1997","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0170_RF14","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.4049\/jimmunol.162.7.4311","article-title":"The role of the human Fc receptor FcRIIA in the immune clearance of platelets: a transgenic mouse model","volume":"162","author":"McKenzie","year":"1999","journal-title":"J Immunol"},{"key":"10.1054\/blre.2001.0170_RF15","first-page":"45","article-title":"Fc receptors for IgG: biological advances and clinical applications","volume":"1","author":"McKenzie","year":"1994","journal-title":"Curr Opin Hematol"},{"key":"10.1054\/blre.2001.0170_RF16","series-title":"Phagocyte Fc receptors for IgG","first-page":"95","author":"McKenzie","year":"1998"},{"key":"10.1054\/blre.2001.0170_RF17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/1074-7613(95)90155-8","article-title":"Cytotoxic antibodies trigger inflammation through Fc receptors","volume":"3","author":"Clynes","year":"1995","journal-title":"Immunity"},{"key":"10.1054\/blre.2001.0170_RF18","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood.V98.8.2442","article-title":"Heparin-induced thrombocytopenia\/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through Fc\u03b3RIIA","volume":"98","author":"Reilly","year":"2001","journal-title":"Blood"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X01901705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X01901705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T05:37:49Z","timestamp":1682141869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X01901705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["S0268960X01901705"],"URL":"https:\/\/doi.org\/10.1054\/blre.2001.0170","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}